They identified a missense variant in the GLP1R gene itself that's associated with an additional -0.76 kg of weight loss per copy of the effect allele meaning some people are genetically primed to lose more, while others lose significantly less
As the medications become increasingly popular (and are due to become cheaper in 2026, when generic versions will hit production), its important to consider the positives and negatives and to be realistic about the effects of these drugs on health and performance
Its possible that employers, commercial insurers and payers in the public sectorincluding Medicaiddecide to eventually revisit their coverage decisions if net prices of GLP-1s decrease sufficiently, combined with more data showing the benefits of weight loss drugs when taken consistently and persistently in conjunction with an appropriate dietary and exercise regimen
By weeks 4 to 8, as your dose stabilizes, the rate may slow to 1 to 1.5 pounds per weekstill significant but more sustainable
This innovative medication offers a promising approach for individuals managing diabetes and seeking effective treatment options